Aqueous humor levels of vascular endothelial growth factor in patients with Coats disease

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-11001350

Enrollment

Unknown

Registered

2011-05-30

Start date

2010-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coats disease

Interventions

Group A:none

Group B:none

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of Coats Disease; 2. Patients must be no older than 18 years; 3. The parents has signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Previous treatment of Coats disease; 2. Surgery or another ocular pathology of any type; 3. Systemic diseases, including diabetes mellitus, congestive heart failure acute renal insufficiency, Chronic renal insufficiency, high blood pressure; 4.Lack of Informed consent.

Design outcomes

Primary

Measure	Time frame
Vascular endothelial growth factor (VEGF);	—

Countries

China

Contacts

Public ContactXiaoyan Peng

drpengxy@gmail.com+86 10 58268285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026